The overall aim is to improve treatments and outcomes for people with osteoporosis. This will be achieved by better predicting those who are likely to fracture and subsequently those who do well post fracture from those who do poorly. Following an osteoporotic fracture there is an increased risk of re- fracture and of premature death. This research will define those risk factors for fracture, re-fracture and early death in a large group of men and women followed for over 20 years.
A Bench To Bedside Approach To Improving Treatment Of Blinding Retinal Diseases
Funder
National Health and Medical Research Council
Funding Amount
$452,051.00
Summary
I am a retinal specialist and clinician scientist directing a group dedicated to identifying improved treatments for blinding macular disease. My clinical research unit conducts randomised clinical trials and pioneered the use of intraocular steroid therapy. My Laboratory research group is interested in stem cell therapy, proteomic analysis of macular disease and the role of Muller cell dysfunction in retinal vascular disease.
The Role Of Obesity, Insulin Resistance And Fatty Liver (steatosis) In Human Disease And Strategies To Monitor And Improve Patient Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$322,892.00
Summary
The overall objective of my research activity is to examine in human subjects, the mechanisms by which obesity and fatty liver impair the response of the liver to injury and inflammation from multiple causes and to develop specific strategies to monitor and improve the outcome of treatment in overweight patients with liver disease.